Status:
COMPLETED
Ropivacaine Plasma Concentrations and Pharmacokinetics Following Erector Spinae Plane Block in the Pediatric Population
Lead Sponsor:
Baylor College of Medicine
Conditions:
Anesthesia, Local
Eligibility:
All Genders
6-18 years
Phase:
PHASE4
Brief Summary
The primary aim of this study is to evaluate the pharmacokinetics of serum ropivacaine concentrations following erector spinae plane peripheral nerve blocks in the pediatric population. Secondary out...
Detailed Description
This pilot study will enroll patients at Texas Children's Hospital, aged 6 months to \<18 years scheduled to undergo a clinically indicated thoracic surgery with the adjunct of an erector spinae plane...
Eligibility Criteria
Inclusion
- Age: 6 months - \< 18 years old;
- Chest tubes or minimally invasive video assisted thoracic surgery;
- Surgery scheduled between 7AM and 5PM
- Weight greater than 4kg
Exclusion
- Renal dysfunction;
- Liver dysfunction;
- Hypoalbuminemia;
- Allergy to local anesthetic;
- Spinal hardware or instrumentation;
- Scoliosis;
- Obesity defined as a BMI \>95% percentile
Key Trial Info
Start Date :
December 18 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 29 2021
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT04298099
Start Date
December 18 2020
End Date
March 29 2021
Last Update
May 17 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Texas Children's Hospital
Houston, Texas, United States, 77030